pdf. Accessed Sept 21, 2013. 29. Schumacher H, Tehrani H, Irwin MS, Malata CM. Abdominoplasty as an adjunct to the management of peri-caesarian section necrotizing fasciitis. J Plast Reconstr Aesthet Surg. 2008;61:807–10.PubMedCrossRef 30. Nissman KW, Nissman DB, Leighton BL, Varaday SS, Lockhart EM. Necrotizing
fasciitis after cesarean section. Anesthesiology. 2011;115:1301.PubMed 31. de Moya MA, del Carmen Aurora Kinase inhibitor MG, Allain RM, Hirschberg RE, Shepard JO, Kradin RL. Case 33-2009: a 35-year-old woman with fever, abdominal pain, and hypotension after cesarean section. N Engl J Med. 2009;361:1689–97.PubMedCrossRef 32. Bernal NP, Latenser BA, Born JM, Liao J. Trends in 393 necrotizing acute soft tissue infection patients. Burns. 2012;38:252–60.PubMedCrossRef 33. Widjaja AB, Tran A, Cleland H, Leung M, Millar I. The hospital costs of treating necrotizing fasciitis. ANZ J Surg. 2005;75:1059–64.PubMedCrossRef 34. Walkey AJ, Wiener RS, Lindenauer PK. Utilization patterns and outcomes
associated with central venous catheter in septic shock: a population-based study. GSK1120212 Crit Care Med. 2013;41:1450–7.PubMedCentralPubMedCrossRef 35. Tillou A, StHill CR, Brown C, Velmahos G. Necrotizing soft tissue infections: improved outcomes with modern care. Am Surg. 2004;70:841–4.PubMed 36. Das DK, Baker MG, Venugopal K. Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand; a retrospective chart review. MRIP BMC Infect Dis. 2012;12:348.PubMedCentralPubMedCrossRef 37. Wunsch H, Angus DC, Harrison DA, et al. Variation in critical care services across North America and Western Europe. Crit
Care Med. 2008;36:2787–93.PubMedCrossRef 38. Seymour CW, Iwashyna TJ, Ehlenbach WJ, Wunsch H, Cooke CR. Hospital-level variation in use of intensive care. Health Serv Res. 2012;47:2060–80.PubMedCentralPubMedCrossRef 39. Endorf FW, Klein MB, Mack CD, Jurkovich GJ, Rivara FP. Necrotizing soft tissue infections: differences in patients treated at burn centers and non-burn centers. J Burn Care Res. 2008;29:933–8.PubMedCentralPubMedCrossRef 40. Facts and figures: statistics on hospital-based care in Texas, 2009. Texas Health Care Information Collection. DSHS Publication # E87-11648. http://www.dshs.state.tx.us/thcic/publications/hospitals/statisticalreports.shtm. Accessed Aug 25, 2013.”
“Introduction The ability of HIV to rapidly mutate and develop resistance to standard antiretroviral therapy (ART) necessitates the ongoing drug development of new and efficacious therapeutic options that are well tolerated and evade prior resistance pathways.